The CenterWatch Weekly, July 31, 2017
Crohn’s & Colitis Foundation launch Clinical Trials Community
On July 20, 2017, the Crohn’s & Colitis Foundation launched a Clinical Trials Community for the education of patients, family members, caregivers and healthcare providers regarding the study of irritable bowel disease (IBD). Specifically, the community will provide education on the clinical trial process as well as its value for facilitating improvements in care. Subsequently, this process may help reduce barriers to patient enrollment in IBD clinical trials, thereby enabling faster routes to therapeutic discovery.
Novotech forges new partnerships in South Korea
July has been a big month for Novotech in South Korea. The Australian-based CRO that operates in 13 countries made two announcements aimed at furthering its presence in one of the hottest CRO markets in the Asia-Pacific region. On July 19 Novotech announced that they launched a new site management organization (SMO) in South Korea. And on July 26 the company announced that it signed a Memorandum of Understanding (MOU) with South Korea’s SCI-Consortium (SCIC) of Clinical Trial Centers and its representative hospital, Severance Hospital, Yonsei University Health System.
To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information.